+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review

  • ID: 4372867
  • SWOT Analysis
  • August 2021
  • 57 pages
  • GlobalData
  • Cipla Inc

FEATURED COMPANIES

  • Aurobindo Pharma Ltd
  • Biocon Ltd
  • Cadila Healthcare Ltd
  • Lupin Ltd
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Cipla Ltd (Cipla) is a pharmaceutical company, which manufactures and distributes branded medicines, generics and active pharmaceutical ingredients (APIs). It offers products in therapeutic areas such as cardiovascular and pediatric diseases, dermatological and cosmetological conditions, HIV/AIDS, diabetes, hepatitis, infectious diseases and critical care, neurological, ophthalmic, malaria, cancer, respiratory and urological conditions, osteoporosis and women's health. The company also operates in consumer healthcare and biosimilar businesses. Cipla manufactures metered-dose inhaler devices, spacers and related devices; and conducts R&D to develop new medicines and drug delivery systems. The company has operations in India, US, Canada, South Africa and major regulated and emerging markets among others. Cipla is headquartered in Mumbai, Maharashtra, India.

Cipla Ltd Key Recent Developments


Jul 31,2021: Cipla Provides Annual Report 2020-21 for 31st Jul 2021
Jul 31,2021: Cipla announce Financial Statements of Subsidiaries FY 2020-21 31st Jul 2021
Jun 30,2021: Indian pharma companies partner to trial molnupiravir for COVID-19
Jun 30,2021: Cipla announces appointment of director
Jun 30,2021: Cipla Announces Notice of 85th Annual General Meeting

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurobindo Pharma Ltd
  • Biocon Ltd
  • Cadila Healthcare Ltd
  • Lupin Ltd
  • MORE

Section 1 - About the Company

  • Cipla Ltd - Key Facts
  • Cipla Ltd - Key Employees
  • Cipla Ltd - Key Employee Biographies
  • Cipla Ltd - Major Products and Services
  • Cipla Ltd - History
  • Cipla Ltd - Company Statement
  • Cipla Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Affiliate
  • Joint Venture

Section 2 - Company Analysis

  • Company Overview
  • Cipla Ltd - Business Description
  • Business Segment: New Ventures
  • Overview
  • Performance
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Rest of the World
  • Performance
  • Geographical Segment: South Africa
  • Performance
  • Geographical Segment: United States of America
  • Performance
  • R&D Overview
  • Cipla Ltd - Corporate Strategy
  • Cipla Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Cipla Ltd - Strengths
  • Cipla Ltd - Weaknesses
  • Cipla Ltd - Opportunities
  • Cipla Ltd - Threats
  • Cipla Ltd - Key Competitors

Section 3 - Company Financial Ratios

  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances

  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Cipla Ltd, Recent Deals Summary

Section 5 - Company’s Recent Developments

  • Jul 31, 2021: Cipla Provides Annual Report 2020-21 for 31st Jul 2021
  • Jul 31, 2021: Cipla announce Financial Statements of Subsidiaries FY 2020-21 31st Jul 2021
  • Jun 30, 2021: Indian pharma companies partner to trial molnupiravir for Covid-19
  • Jun 30, 2021: Cipla announces appointment of director
  • Jun 30, 2021: Cipla Announces Notice of 85th Annual General Meeting
  • May 14, 2021: Cipla : Appointment of director
  • Apr 28, 2021: Merck signs licensing deals with five Indian firms for Oral Covid-19 drug
  • Mar 23, 2021: Cipla Therapeutics and SIGA Technologies announce strategic partnership to support innovation and provide access to novel antibacterial drugs against biothreats
  • Mar 23, 2021: Cipla Therapeutics: Intimation of re-appointment of managing director
  • Mar 02, 2021: Cipla Gulf expands partnership with Alvotech for commercialization of biosimilars in Australia and New Zealand

Section 6 - Appendix

  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer

List of Tables

  • Cipla Ltd, Key Facts
  • Cipla Ltd, Key Employees
  • Cipla Ltd, Key Employee Biographies
  • Cipla Ltd, Major Products and Services
  • Cipla Ltd, History
  • Cipla Ltd, Subsidiaries
  • Cipla Ltd, Affiliate
  • Cipla Ltd, Joint Venture
  • Cipla Ltd, Key Competitors
  • Cipla Ltd, Ratios based on current share price
  • Cipla Ltd, Annual Ratios
  • Cipla Ltd, Annual Ratios (Cont...1)
  • Cipla Ltd, Annual Ratios (Cont...2)
  • Cipla Ltd, Interim Ratios
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • Cipla Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures

  • Cipla Ltd, Performance Chart (2017 - 2021)
  • Cipla Ltd, Ratio Charts
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • Cipla Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Note: Product cover images may vary from those shown

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • Dr. Reddy's Laboratories Ltd
  • Biocon Ltd
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd
  • Cadila Healthcare Ltd
  • Lupin Ltd
  • Torrent Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
Adroll
adroll